We are happy to share that MSB Clinical Research Center is now activated for Phase 2 clinical trial for
patients with Generalized Myasthenia Gravis.
We are proud to be one of only two sites in Serbia where this ground-breaking clinical trial will be
available – advancing medical knowledge and improving patient outcomes with gMG.
Our remarkable team of neurologists is eagerly awaiting to enroll our first patients. Our mission has
always been to deliver the highest standard of care to our patients, and this clinical trial is a
testament to our unwavering commitment to medical innovation.